ArticleNPJ breast cancer2021
Evolution of HER2-low expression from primary to recurrent breast cancer.
Federica Miglietta et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
144 papers cite itlatest 60 shown
this paperpooled ittrialcites it